Sign in Register

Drug class

Antiarrhythmic - Class IB (Systemic)

Antiarrhythmic Class IB (Systemic) is a therapeutic category of cardiac medications that includes systemic agents such as lidocaine and mexiletine. Read more about Antiarrhythmic - Class IB (Systemic)

86 drugs in this class 56 manufacturers

Related classes & indications

Calcium Channel BlockersCardiovascular & renal · 344 prescription drugs Angiotensin II Receptor Antagonists (ARBs)Cardiovascular & renal · 281 prescription drugs Administration Of Local AnesthesiaTop indication · 358 prescription drugs

Showing 19–27 of 86 drugs

Sort

LIDOCAINE HCL-EPINEPHRINE-NACL (lidocaine HCl/epinephrine in sodium chloride, iso-osmotic)

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC)

QUVA PHARMA, IN

LIDOCAINE HCL

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC) · PRURITUS OF SKIN ·+2

BROOKFIELD PHAR

LIDOCAINE-EPINEPHRINE BIT (lidocaine HCl/epinephrine bitartrate)

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC) · ADMINISTRATION OF LOCAL ANESTHESIA

PATTERSON DENTA

LIDOCAINE-EPINEPHRINE BIT (lidocaine HCl/epinephrine bitartrate)

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC) · ADMINISTRATION OF LOCAL ANESTHESIA

HENRY SCHEIN

LIDOCAINE-EPINEPHRINE BIT (lidocaine HCl/epinephrine bitartrate)

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC) · ADMINISTRATION OF LOCAL ANESTHESIA

COOK WAITE/CARE

LIDOCAINE-EPINEPHRINE BIT (lidocaine HCl/epinephrine bitartrate)

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC) · ADMINISTRATION OF LOCAL ANESTHESIA

BENCO DENTAL

XYLOCAINE (lidocaine HCl)

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC) · ADMINISTRATION OF LOCAL ANESTHESIA

FRESENIUS KABI

BUFFERED LIDOCAINE (lidocaine HCl buffered with 8.4 % sodium bicarbonate)

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC)

NEPHRON/OF

XYLOCAINE WITH EPINEPHRINE (lidocaine HCl/epinephrine)

ANTIARRHYTHMIC - CLASS IB (SYSTEMIC) · ADMINISTRATION OF LOCAL ANESTHESIA

FRESENIUS KABI

Filter & compare in the drug finder → Opens the drug finder with Antiarrhythmic - Class IB (Systemic) preselected. Add indication or manufacturer filters there.

About Antiarrhythmic - Class IB (Systemic).

Antiarrhythmic Class IB (Systemic) is a therapeutic category of cardiac medications that includes systemic agents such as lidocaine and mexiletine.

These drugs act by selectively binding and producing a mild, rapid-dissociation blockade of fast voltage-gated cardiac sodium channels, particularly in depolarized, ischemic, or rapidly firing myocardial tissue, which shortens the action potential duration and effective refractory period.

Clinically, systemic class IB agents are primarily indicated for the acute suppression and chronic prevention of ventricular arrhythmias, notably ventricular tachycardia and ventricular fibrillation associated with myocardial infarction or cardiac ischemia, as well as selected congenital long QT syndromes.

nih.gov
Antiarrhythmic Class IB (Systemic) is a therapeutic category of cardiac medications that includes systemic agents such as lidocaine and mexiletine These drugs act by selectively binding and producing a mild, rapid-dissociation blockade of fast voltage-gated cardiac sodium channels, particularly in depolarized, ischemic, or rapidly firing myocardial tissue, which shortens the action potential duration and effective refractory period Clinically, systemic class IB agents are primarily indicated for...
nih.gov
Antiarrhythmic Class IB (Systemic) is a therapeutic category of cardiac medications that includes systemic agents such as lidocaine and mexiletine
nih.gov
These drugs act by selectively binding and producing a mild, rapid-dissociation blockade of fast voltage-gated cardiac sodium channels, particularly in depolarized, ischemic, or rapidly firing myocardial tissue, which shortens the action potential duration and effective refractory period
nih.gov
These drugs act by selectively binding and producing a mild, rapid-dissociation blockade of fast voltage-gated cardiac sodium channels, particularly in depolarized, ischemic, or rapidly firing myocardial tissue, which shortens the action potential duration and effective refractory period
nih.gov
Clinically, systemic class IB agents are primarily indicated for the acute suppression and chronic prevention of ventricular arrhythmias, notably ventricular tachycardia and ventricular fibrillation associated with myocardial infarction or cardiac ischemia, as well as selected congenital long QT syndromes